sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Generic Injectables Market...

Europe Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Large Molecule Injectables and Small Molecule Injectables), Container Type (Vials, Premix, Prefilled Syringes, Ampoules, and Others), Application (Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology, and Others), and Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others) 

BMIRE00024997 | Pages: 177 | Pharmaceuticals | Jun 2022 | Type: Regional | Status: Published

The generic injectables market in Europe is expected to grow from US$ 17,827.88 million in 2021 to US$ 34,509.74 million by 2028; it is estimated to grow at a CAGR of 9.9% from 2021 to 2028.

Innovator drugs are expensive owing to high investments made in the research & development of molecules; these drugs are specifically unaffordable for a large share of the population in developing countries. However, generic drugs are affordable and provide greater access to healthcare. Additionally, the generic drug’s average manufacturer prices (AMP) are 39% lower than the branded drug’s AMP. The facts mentioned above boost the demand and availability of generic injectables, thus driving more players into the generic injectables market. Further, low prices of generic injectables contribute to greater and more effective chronic illness treatments. Generic injectables such as insulin injections offer immediate solutions for such ailments, ensuring affordable treatments in developing countries.

Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :


Europe Generic Injectables Market Segmentation  

The Europe generic injectables market is segmented into product type, container type, application, route of administration, and country. Based on product type, the market has been segmented into large molecule injectable and small molecule injectable. In 2020, the large molecule injectable segment held a larger market share. In terms of container type, the market has been categorized into vials, premix, prefilled syringes, ampoules, and others. In 2020, the vials segment held the largest share of the market. Based on application, the market has been segmented into oncology, infectious diseases, cardiology, diabetes, immunology, and others. In 2020, the oncology segment held the largest share of the market. Based on route of administration, the market has been categorized into intravenous, intramuscular, subcutaneous, and others. In 2020, the intravenous segment held the largest market share. Based on country, the Europe generic injectables market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany contributed a substantial share in 2020. 

AstraZeneca; Baxter International Inc.; Biocon; Fresenius SE & Co. KGaA; GlaxoSmithKline plc; Hikma Pharmaceuticals PLC; Johnson and Johnson Services, Inc.; Lupin; Merck & Co., Inc.; Pfizer Inc.; and Viatris Inc are among the leading companies in the Europe generic injectables market are among the leading companies in the Europe generic injectables market.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Generic injectables Market – By Product Type

1.3.2        Europe Generic injectables Market – By Container Type

1.3.3        Europe Generic injectables Market – By Application

1.3.4        Europe Generic injectables Market – By Route of Administration

1.3.5        Europe Generic injectables Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Generic Injectables Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Generic Injectables Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Low R&D, Marketing, and Manufacturing Costs

5.1.2        Increasing Demand for Affordable Drugs

5.2         Market Restraints

5.2.1        Critical Inspection System for Prefilled Injection

5.3         Market Opportunities

5.3.1        Increasing Patent Expiry of Drugs

5.4         Future Trends

5.4.1        Government Support for Generic Injectables Production and Healthcare Cost Reduction

5.5         Impact Analysis

6.           Generic Injectables Market– Europe Analysis

6.1         Europe Generic Injectables Market Revenue Forecast and Analysis

7.           Europe Generic Injectables Market– by Product Type

7.1         Overview

7.2         Europe Generic Injectables Market, By Product Type, 2021 & 2028 (%)

7.3         Large Molecule Injectables

7.3.1        Overview

7.3.2        Large Molecule Injectables: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

7.4         Small Molecule Injectables

7.4.1        Overview

7.4.2        Small Molecule Injectables: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.           Europe Generic Injectables Market– by Container Type

8.1         Overview

8.2         Europe Generic Injectables Market, By Container Type, 2021 & 2028 (%)

8.3         Vials

8.3.1        Overview

8.3.2        Vials: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.4         Premix

8.4.1        Overview

8.4.2        Premix: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.5         Prefilled Syringes

8.5.1        Overview

8.5.2        Prefilled Syringes: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.6         Ampoules

8.6.1        Overview

8.6.2        Ampoules: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.           Europe Generic Injectables Market– by Application

9.1         Overview

9.2         Europe Generic Injectables Market, By Application, 2021 & 2028 (%)

9.3         Oncology

9.3.1        Overview

9.3.2        Oncology: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.4         Infectious Diseases

9.4.1        Overview

9.4.2        Infectious Diseases: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.5         Cardiology

9.5.1        Overview

9.5.2        Cardiology: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.6         Diabetes

9.6.1        Overview

9.6.2        Diabetes: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.7         Immunology

9.7.1        Overview

9.7.2        Immunology: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.8         Others

9.8.1        Overview

9.8.2        Others: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.        Europe Generic Injectables Market– by Route of Administration

10.1      Overview

10.2      Europe Generic Injectables Market, By Route of Administration, 2021 & 2028 (%)

10.3      Intravenous

10.3.1     Overview

10.3.2     Intravenous: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.4      Intramuscular

10.4.1     Overview

10.4.2     Intramuscular: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.5      Subcutaneous

10.5.1     Overview

10.5.2     Subcutaneous: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

11.        Europe Generic Injectables Market– Country Analysis

11.1      Europe: Generic Injectables Market

11.1.1     Overview

11.1.3     Europe: Generic Injectables Market, Revenue and Forecast to 2028, By Country (%)

11.1.3.1       Germany: Generic Injectables Market -Revenue and Forecast to 2028 (US$ Million)

11.1.3.1.1       Germany: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)

11.1.3.1.2       Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)

11.1.3.1.3       Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

11.1.3.1.4       Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)

11.1.3.1.5       Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

11.1.3.2       France: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

11.1.3.2.1       France: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)

11.1.3.2.2       France: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)

11.1.3.2.3       France: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

11.1.3.2.4       France: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)

11.1.3.2.5       France: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

11.1.3.3       UK: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.3.1       UK: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.3.2       UK: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)

11.1.3.3.3       UK: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

11.1.3.3.4       UK: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)

11.1.3.3.5       UK: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

11.1.3.4       Italy: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.4.1       Italy: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.4.2       Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)

11.1.3.4.3       Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

11.1.3.4.4       Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)

11.1.3.4.5       Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

11.1.3.5       Spain: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.5.1       Spain: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.5.2       Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)

11.1.3.5.3       Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

11.1.3.5.4       Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)

11.1.3.5.5       Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

11.1.3.6       Rest of Europe: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.6.1       Rest of Europe: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.6.2       Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)

11.1.3.6.3       Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

11.1.3.6.4       Rest of Europe: Product Type Market- Revenue and Forecast to 2028, By Application (US$ Million)

11.1.3.6.5       Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

12.        Europe Generic Injectables Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      AstraZeneca

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Baxter International Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Biocon

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Fresenius SE & Co. KGaA

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      GlaxoSmithKline plc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Hikma Pharmaceuticals PLC

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Johnson and Johnson Services, Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Lupin

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Viatris Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Merck & Co., Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

13.11   Pfizer Inc.

13.11.1  Key Facts

13.11.2  Business Description

13.11.3  Products and Services

13.11.4  Financial Overview

13.11.5  SWOT Analysis

13.11.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Europe Generic injectables Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)

Table 3.             Germany Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

Table 4.             Germany Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)

Table 5.             Germany Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

Table 6.             France Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

Table 7.             France Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)

Table 8.             France Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

Table 9.             UK Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)

Table 10.          UK: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

Table 11.          UK Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)

Table 12.          UK: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

Table 13.          Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)

Table 14.          Italy Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

Table 15.          Italy Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)

Table 16.          Italy Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

Table 17.          Spain Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)

Table 18.          Spain Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

Table 19.          Spain Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)

Table 20.          Spain Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

Table 21.          Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)

Table 22.          Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)

Table 23.          Rest of Europe Product Type Market- Revenue and Forecast to 2028, By Application (US$ Million)

Table 24.          Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic Developments Done By Companies

Table 27.          Glossary of Terms, Europe Generic Injectables Market

 


LIST OF FIGURES

Figure 1.           Europe Generic injectables Market Segmentation

Figure 2.           Europe Generic injectables Market, By Country

Figure 3.           Europe Generic Injectables Market Overview

Figure 4.           Large Molecule Injectable Segment Held Largest Share of Product Type Segment in Europe Generic injectables Market

Figure 5.           UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Europe Generic injectables Market Impact Analysis of Driver and Restraints

Figure 9.           Europe Generic injectables Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        Europe Generic Injectables Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Large Molecule Injectables: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Small Molecule Injectables: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Generic Injectables Market, by Container Type, 2021 & 2028 (%)

Figure 14.        Vials: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Premix: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Prefilled Syringes: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Ampoules: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Others: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Europe Generic Injectables Market, by Application, 2021 & 2028 (%)

Figure 20.        Oncology: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Infectious Diseases: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Cardiology: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diabetes: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Immunology: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Others: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Europe Generic Injectables Market, by Route of Administration, 2021 & 2028 (%)

Figure 27.        Intravenous: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Intramuscular: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Subcutaneous: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Others: Europe Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Europe: Generic Injectables Market, Revenue Overview, by Country, 2021 (US$ Million)

Figure 32.        Europe Generic Injectables Market, Revenue and Forecast to 2028, By Country (%)

Figure 33.        Germany Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)

Figure 34.        France: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)

Figure 35.        UK: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Italy: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Spain: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Rest of Europe: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
  1. AstraZeneca
  2. Baxter International Inc.
  3. Biocon
  4. Fresenius SE & Co. KGaA
  5. GlaxoSmithKline plc
  6. Hikma Pharmaceuticals PLC
  7. Johnson and Johnson Services, Inc.
  8. Lupin
  9. Merck & Co., Inc.
  10. Pfizer Inc.
  11. Viatris Inc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Generic Injectables Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe Generic Injectables Market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Generic Injectables Market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3000
$1500
Site License
$4000
$2000
Enterprise License
$5000
$2500
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription